Which malignancies are potential adverse effects of immunosuppressants in liver transplant patients?

Updated: Dec 31, 2017
  • Author: Lemi Luu, MD, RDMS, FACEP, FAAEM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print
Answer

Answer

One of the adverse effects of immunosuppressants is the increased risk of malignancy, which is the second leading cause of late death in liver transplant recipients. Patients are at increased risk of developing lymphomas, squamous cell carcinoma, and posttransplant lymphoproliferative disorder. Squamous cell carcinoma of the skin is the more common posttransplant malignancy. However, no increased risk exists of developing colon, prostate, breast, or lung cancer.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!